CAS 1613191-99-3

2-Amino-6-fluoro-N-[5-fluoro-4-[4-[[4-(3-oxetanyl)-1-piperazinyl]carbonyl]-1-piperidinyl]-3-pyridinyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

CAS: 1613191-99-3

Fórmula: C₂₅H₂₉F₂N₉O₃

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 541.5531

Ref: IN-DA01DGYV

Gartisertib

CAS: 1613191-99-3

Gartisertib

Fórmula: C₂₅H₂₉F₂N₉O₃

Pureza: ≥98%

Peso molecular: 541.55

Ref: 54-BUP17969

Gartisertib

CAS: 1613191-99-3

2-Amino-6-fluoro-N-(5-fluoro-4-(4-(4-(oxetan-3-yl)piperazine-1-carbonyl)piperidin-1-yl)pyridin-3-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

Fórmula: C₂₅H₂₉F₂N₉O₃

Pureza: 98%

Peso molecular: 541.55

Ref: IN-DG00836845

Atr inhibitor 2

CAS: 1613191-99-3

Atr inhibitor 2 is a cellular inhibitor that binds to the target of a drug. This binding prevents the drug from interacting with the receptor, thereby inhibiting the activity of the drug. The cellular inhibitor may be an endogenous protein or it may be synthesized by chemical synthesis. Atr inhibitor 2 has been shown to inhibit hepatitis C virus and human immunodeficiency virus (HIV) by binding to their RNA molecules. It also inhibits cancer cells in vitro and in vivo. The drugs that are targeted by this inhibitor include medicines for treating diseases such as HIV, hepatitis, and cancer. This drug can also be used as a research tool for studying viral replication, translation, and protein synthesis.

Fórmula: C₂₅H₂₉F₂N₉O₃

Pureza: Min. 95%

Peso molecular: 541.6 g/mol

Ref: 3D-NPC19199

Gartisertib

CAS: 1613191-99-3

Gartisertib (VX-803) is an ATR inhibitor with anti-tumor activity, inhibiting the anti-proliferative effects induced in ccRCC cells.

Fórmula: C₂₅H₂₉F₂N₉O₃

Pureza: 99.52%

Cor e Forma: Solid

Peso molecular: 541.55

Ref: TM-T10407